Please wait while we open this resource.
K
Clinical reviews
DYSLIPIDAEMIA AND HEPATIC STEATOSIS: MECHANISMS AND IMPLICATIONS FOR LIPID-LOWERING THERAPY
Maurizio Averna, M. Mahmood Hussain, Giuseppe Danilo Norata
PDF202616 pages1.6 MB
Dyslipidaemia and hepatic steatosis are recognized as metabolic disorders that contribute significantly to cardiovascular disease. The article explores various mechanisms that lead to lipid accumulation in the liver, including impaired fatty acid oxidation and the effects of lipid-lowering therapies. It emphasizes the need for careful monitoring of hepatic lipid content in patients undergoing treatment and highlights the potential for new therapeutics that can effectively manage lipid levels without causing steatosis.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology